Prevalence of hepatitis C virus seropositivity among hospitalized US veterans

American Journal of the Medical Sciences

Volumn 319, Issue 6, 2000, Pages 353-359

  Austin, Garth E ^a,b   Jensen, Bette ^a,b   Leete, Jean ^c   De L'Aune, William ^a,b   Bhatnagar, Julu ^a   Racine, Michele ^a   Braun, Joshua E ^a  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Hepatitis C; Risk factors; Seropositivity; Veterans

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ALCOHOL ABUSE; ARTICLE; BLOOD TRANSFUSION; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SOLDIER; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 0034126567     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200006000-00002     Document Type: Article

References (20)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-19):1-39.
2. Fried MW, Hoofnagle JH. Therapy of hepatitis C. Semin Liver Dis 1995;15:82-91.
3. Katkov WN, Dienstag JL, Cody H, et al. Role of hepatitis C virus in non-B chronic liver disease. Arch Intern Med 1991;151:1548-52.
4. Levrero M, Tagger A, Balsano C, et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatology 1991;12:60-3.
5. McQuillan GM, Alter MJ, Moyer LA, et al. A population based serologic study of hepatitis C virus infection in the United States. In Rizzetto M, Purcell RH, Gerin JL, et al, editors. Viral hepatitis and liver disease. Turin, Italy: Edizioni Minerva Medica; 1997. p. 267-70.
6. Houghton M, Weiner A, Han J, et al. Molecular biology of the hepatitis C viruses: implications for diagnosis, development, and control of viral disease. Hepatology 1991;14:381-8.
7. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;224:359-62.
8. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:359-62.
9. Estaban JJ, Gonzalez A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-12.
10. Allain JP, Coghlan PJ, Kenrick KG, et al. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood 1991;78:2462-8.
11. Cristiano K, Di Bisceglie AM, Hoofnagle JH, et al. Hepatitis C viral RNA in serum and plasma of patients with chronic non-A, non-B hepatitis: detection by polymerase chain reaction using multiple primer sets. Hepatology 1991; 151:1548-52.
12. Seeff LB, Wright EC, Zimmerman HJ, et al. VA Cooperative Studies Group. VA cooperative study of post-transfusion hepatitis and responsible risk factors. Am J Med Sci 1975;270:355-62.
13. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26: 62S-65S.
14. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339: 1493-9.
15. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-92.
16. Management of hepatitis C. NIH Consensus Statement On-line. 1997 Mar 24-26;15(3):1-41.
17. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first- and second-generation assays. N Engl J Med 1991;325: 1325-9.
18. Austin GE, Jensen B, Racine M, et al. Prevalence of hepatitis C virus seropositivity in patients at a U.S. veterans administration hospital. Clin Chem 1996;42:S246.
19. Bocher M, Vockel A. MATRIX HCV - a newly developed semiautomated dot-immunoassay. Beitr Infusionsther Transfusionsmed 1994;32:120-3.
20. Kalton G. Introduction to survey sampling series. Quantitative applications in the social sciences, number 35. Beverly Hills (CA): Sage Publications; 1983.